Pouch drug delivery systems for dermal and transdermal administration

Jana Zailer, Elka Touitou*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

In this work, we have designed and investigated a new carrier for dermal and transdermal drug delivery. The delivery system is composed of high (>60 %) ethanol concentration, phospholipid, polymer, and water. The system forms a structured matrix following non-occluded application on the skin. We call these structured carriers as pouch drug delivery systems (PDDS). The pouch-structured matrix was characterized by electron microscopy, 31P-NMR and FTIR. The new delivery system exhibits a number of properties adequate for the design of improved dermal and transdermal drug administration for various treatments. Lidocaine PDDS dry faster and has an enhanced dermal drug delivery when compared to a clinical-used product. These proprieties are important for the prevention of premature ejaculation. Results obtained in pharmacodynamics test carried out with brotizolam PDDS in a mice-sleeping model and with ibuprofen PDDS in fevered rats indicated a prolonged hypnotic and antipyretic effect, respectively. The carrier was found nonirritant in tests carried out on EpiDermTM skin model.

Original languageEnglish
Pages (from-to)416-428
Number of pages13
JournalDrug Delivery and Translational Research
Volume4
Issue number5-6
DOIs
StatePublished - 18 Nov 2014

Bibliographical note

Publisher Copyright:
© 2014, Controlled Release Society.

Keywords

  • Antipyretic
  • Brotizolam
  • Dermal
  • Ethanol
  • Hypnotic
  • Ibuprofen
  • Lidocaine
  • Phospholipid
  • Transdermal

Fingerprint

Dive into the research topics of 'Pouch drug delivery systems for dermal and transdermal administration'. Together they form a unique fingerprint.

Cite this